Specialty Pharmacy Implementation

DPCI has entered into an agreement with Curascript Pharmacy to provide specialty pharmacy products to provider offices for our members. Effective October 1, 2007, a new pharmacy authorization form will need to be utilized for any of the injectables and associated infusions that are provided in a physician’s office. This process is related to injectable drugs and infusions (J-codes, Q-codes) that generally are subject to prior authorization. If you have billed DPCI in the past for one of the J-codes or Q-codes that require prior authorization, you should have received a letter detailing this new process. If you bill J-codes and Q-codes to DPCI and have not received a letter, please contact Taunja Durham (302) 894-6723 or Jamie McCarrick (302) 894-6733.

Self administered injectables are available through the Delaware Medicaid pharmacy benefit administered by EDS. Members should be directed to Delaware retail pharmacies with prescriptions to obtain these drugs. If there are clinical exceptions that require the injectable drug to be given in the office setting, please submit the clinical documentation to support the office administration with this request.

Click the following link to view notification sent to providers.
Specialty Pharmacy Provider Letter